Eosinophils, bronchitis and asthma: pathogenesis of cough and airflow obstruction.

[1]  Salman Siddiqui,et al.  IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitis , 2009, BMC pulmonary medicine.

[2]  C. Brightling,et al.  Airway wall geometry in asthma and nonasthmatic eosinophilic bronchitis , 2009, Allergy.

[3]  Ana Sousa,et al.  Mepolizumab and exacerbations of refractory eosinophilic asthma. , 2009, The New England journal of medicine.

[4]  I. Pavord,et al.  Airway hyperresponsiveness is dissociated from airway wall structural remodeling. , 2008, The Journal of allergy and clinical immunology.

[5]  I. Pavord,et al.  Increased sputum and bronchial biopsy IL-13 expression in severe asthma. , 2008, The Journal of allergy and clinical immunology.

[6]  W. Busse,et al.  A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. , 2007, American journal of respiratory and critical care medicine.

[7]  Hirofumi Matsuoka,et al.  Prognosis of Cough Variant Asthma: A Retrospective Analysis , 2006, The Journal of asthma : official journal of the Association for the Care of Asthma.

[8]  P. Dicpinigaitis.  Chronic cough due to asthma: ACCP evidence-based clinical practice guidelines. , 2006, Chest.

[9]  Choon-Sik Park,et al.  Interleukin-13 and interleukin-5 in induced sputum of eosinophilic bronchitis: comparison with asthma. , 2005, Chest.

[10]  I. Pavord,et al.  Observational study of the natural history of eosinophilic bronchitis , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  I. Pavord,et al.  Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. , 2004, The Journal of allergy and clinical immunology.

[12]  S. Phipps,et al.  Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. , 2003, The Journal of clinical investigation.

[13]  S. Ayik,et al.  Eosinophilic bronchitis as a cause of chronic cough. , 2003, Respiratory medicine.

[14]  I. Pavord,et al.  Comparison of airway immunopathology of eosinophilic bronchitis and asthma , 2003, Thorax.

[15]  A. Kay,et al.  Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. , 2003, American journal of respiratory and critical care medicine.

[16]  I. Pavord,et al.  Mast-cell infiltration of airway smooth muscle in asthma. , 2002, The New England journal of medicine.

[17]  R. Hancox,et al.  Eosinophilic bronchitis , 2001, The Lancet.

[18]  V. Stern.  Decisions at end of life , 2001, The Lancet.

[19]  K. Chung,et al.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.

[20]  I. Pavord,et al.  Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial , 2000, The Lancet.

[21]  A. Dvorak,et al.  Ultrastructural analysis of human eosinophils. , 2000, Chemical immunology.

[22]  B. Edwards,et al.  Expression of P-Selectin at Low Site Density Promotes Selective Attachment of Eosinophils Over Neutrophils1 , 2000, The Journal of Immunology.

[23]  F. Symon,et al.  HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Interleukin-13 induces PSGL-1/P–selectin–dependent adhesion of eosinophils, , 2022 .

[24]  I. Pavord,et al.  Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. , 2000, The European respiratory journal.

[25]  P. O'Byrne,et al.  Induced sputum cell counts in healthy adults. , 2000, American journal of respiratory and critical care medicine.

[26]  Paige Lacy,et al.  Eosinophil cytokines. , 2000, Chemical immunology.

[27]  I. Pavord,et al.  Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. , 2000, American journal of respiratory and critical care medicine.

[28]  A. Wardlaw.  Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm. , 1999, The Journal of allergy and clinical immunology.

[29]  I. Pavord,et al.  Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma. , 1999, The European respiratory journal.

[30]  A J Wardlaw,et al.  Eosinophilic bronchitis is an important cause of chronic cough. , 1999, American journal of respiratory and critical care medicine.

[31]  J. Erjefält,et al.  Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways. , 1999, American journal of respiratory and critical care medicine.

[32]  F. Hargreave,et al.  Nonasthmatic chronic cough: No effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. , 1999, Canadian respiratory journal.

[33]  I. Pavord,et al.  Non-eosinophilic cor ticosteroid unresponsive asthma , 1999, The Lancet.

[34]  J. Denburg.  Bone marrow in atopy and asthma: hematopoietic mechanisms in allergic inflammation. , 1999, Immunology today.

[35]  F. Hargreave,et al.  Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. , 1998, American journal of respiratory and critical care medicine.

[36]  M. Ennis,et al.  Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol , 1998, Thorax.

[37]  W. Sewell,et al.  Chronic cough resembles asthma with IL-5 and granulocyte-macrophage colony-stimulating factor gene expression in bronchoalveolar cells. , 1998, Journal of Allergy and Clinical Immunology.

[38]  C. Lemière,et al.  Occupational eosinophilic bronchitis without asthma: an unknown occupational airway disease. , 1997, The Journal of allergy and clinical immunology.

[39]  A. Dvorak,et al.  Eosinophil Lipid Bodies: Specific, Inducible Intracellular Sites for Enhanced Eicosanoid Formation , 1997, The Journal of experimental medicine.

[40]  P. Gibson,et al.  A systematic evaluation of mechanisms in chronic cough. , 1997, American journal of respiratory and critical care medicine.

[41]  G. Gleich,et al.  Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function. , 1997, The American journal of physiology.

[42]  F. Symon,et al.  Functional and structural characterization of the eosinophil P-selectin ligand. , 1996, Journal of immunology.

[43]  P. Gibson,et al.  Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[44]  G. Gleich,et al.  Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. , 1991, The Journal of clinical investigation.

[45]  R. Irwin,et al.  Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. , 1990, The American review of respiratory disease.

[46]  J. Denburg,et al.  CHRONIC COUGH: EOSINOPHILIC BRONCHITIS WITHOUT ASTHMA , 1989, The Lancet.

[47]  R. Irwin,et al.  Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. , 2015, The American review of respiratory disease.

[48]  S. Braman,et al.  Chronic cough as the sole presenting manifestation of bronchial asthma. , 1979, The New England journal of medicine.

[49]  J. Gerrard,et al.  Letter: Sex-linked mental retardation. , 1974, Lancet.